ZDA
CMLTU

Zweig-DiMenna Associates’s CM Life Sciences III Inc. Unit CMLTU Stock Holding History

Zweig-DiMenna Associates’s Portfolio CMLTU Stock Details CMLTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-74,874
Closed -$820K – 222
2021
Q2 		$820K Buy
+74,874
New +$807K 0.05% 171

Other funds holding CMLTU

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Zweig-DiMenna Associates's CMLTU Position: Q3 2021 in Review

Zweig-DiMenna Associates sold out of CM Life Sciences III Inc. Unit (CMLTU) in Q3 2021, closing a stake of 74,874 shares — an estimated $820K sold.

Zweig-DiMenna Associates first reported a position in CMLTU in Q2 2021 and held it in 1 quarter. The position peaked at $820K in Q2 2021. 28 funds tracked by Wall St. Rank hold CMLTU as of Q3 2021.

  • Zweig-DiMenna Associates reported no remaining CM Life Sciences III Inc. Unit position as of Q3 2021 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 74,874 CM Life Sciences III Inc. Unit shares in Q3 2021, an estimated $820K.
  • Zweig-DiMenna Associates first reported a position in CM Life Sciences III Inc. Unit in Q2 2021 and held it in 1 quarter.
  • Zweig-DiMenna Associates's CM Life Sciences III Inc. Unit position peaked at $820K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held CM Life Sciences III Inc. Unit as of Q3 2021.

Based on Zweig-DiMenna Associates's 13F filing for Q3 2021, filed 25 Oct 2021.